Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,050.00
+120.00 (2.02%)
At close: Feb 3, 2026

Dongwha Pharm.Co.,Ltd Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
164,367174,623284,265256,309404,115542,492
Market Cap Growth
-9.19%-38.57%10.91%-36.58%-25.51%136.46%
Enterprise Value
288,036241,058195,948161,993319,081430,132
Last Close Price
5930.006122.269698.238586.4313284.4317657.44
PE Ratio
21.6631.3910.3612.5722.6119.03
PS Ratio
0.330.380.790.751.381.99
PB Ratio
0.410.430.700.681.121.58
P/TBV Ratio
0.560.600.880.741.231.73
P/FCF Ratio
--61.4523.7528.6930.17
P/OCF Ratio
36.52-9.758.7711.2210.39
EV/Sales Ratio
0.580.520.540.481.091.58
EV/EBITDA Ratio
10.247.296.023.829.2212.73
EV/EBIT Ratio
40.5917.9710.505.4214.1818.64
EV/FCF Ratio
-5.32-42.3615.0122.6523.92
Debt / Equity Ratio
0.310.240.120.020.030.05
Debt / EBITDA Ratio
4.392.931.450.160.330.46
Debt / FCF Ratio
--10.180.620.820.87
Asset Turnover
0.800.790.710.750.670.67
Inventory Turnover
3.063.132.913.843.793.66
Quick Ratio
0.861.081.562.342.802.75
Current Ratio
1.541.792.263.063.373.36
Return on Equity (ROE)
0.92%0.53%7.21%5.83%5.55%8.92%
Return on Assets (ROA)
0.71%1.42%2.29%4.11%3.19%3.56%
Return on Invested Capital (ROIC)
0.60%1.02%4.45%10.56%6.77%9.25%
Return on Capital Employed (ROCE)
1.40%2.80%4.10%7.70%5.90%6.30%
Earnings Yield
4.62%3.19%9.65%7.95%4.42%5.25%
FCF Yield
-32.91%-23.30%1.63%4.21%3.49%3.31%
Dividend Yield
2.97%2.94%1.86%2.10%1.35%1.02%
Payout Ratio
65.71%89.68%18.16%24.44%27.81%11.62%
Buyback Yield / Dilution
-0.15%-0.12%-0.02%-0.16%-0.05%-0.05%
Total Shareholder Return
2.81%2.82%1.83%1.93%1.31%0.97%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.